Acer Therapeutics Inc. ACER
Set alert
0.66 0.00 0.00%
As of Nov 20, 3:59 PM ET
0.6601 Day range 0.85
52-week range unavailable
- Open
- 0.7968
- Prev close
- 0.6601
- Mkt cap
- 0
- Vol
- 574.67K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6601
- High
- 0.85
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
ACER Revenue — quarterly 0
ACER Net income — quarterly -8.09M
ACER EPS — quarterly -0.33
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Nov 20, 2023 | Sep 1, 2023 | -0.13 | -0.53 | -0.40 | -307.69% |
| Aug 14, 2023 | Jun 1, 2023 | -0.26 | -0.23 | +0.03 | +11.54% |
News
- Russian LNG on the rise in EU – report
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
- PC demand is back, says Acer CEO who sees robust growth in the 'foreseeable future'
- ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER
- ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Acer (ACER) to Get Acquired by Zevra for $91M, Stock Up
- Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra
- ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders
- Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
Your note
Sign in to keep a note on ACER — it syncs with the Stock Master app.